AstraZeneca PLC vs Philip Morris International Inc.
Market cap comparison over time
AstraZeneca PLC
$285.4B
Rank #45
Philip Morris International Inc.
$305.6B
Rank #40
Market Cap Over Time
Key Moments
- Philip Morris International Inc. overtook AstraZeneca PLC by 2010
- AstraZeneca PLC overtook Philip Morris International Inc. by 2014
- Philip Morris International Inc. overtook AstraZeneca PLC by 2015
- AstraZeneca PLC overtook Philip Morris International Inc. by 2018
- Philip Morris International Inc. overtook AstraZeneca PLC by 2026
Year-by-Year Comparison
| Year | AstraZeneca PLC | Philip Morris International Inc. | Leader |
|---|---|---|---|
| 2026 | $285.4B | $305.6B | Philip Morris International Inc. |
| 2025 | $282.2B | $245.5B | AstraZeneca PLC |
| 2024 | $196.9B | $177.6B | AstraZeneca PLC |
| 2023 | $198.1B | $131.8B | AstraZeneca PLC |
| 2022 | $195.3B | $134.5B | AstraZeneca PLC |
| 2021 | $163.9B | $119.6B | AstraZeneca PLC |
| 2020 | $136.9B | $99.0B | AstraZeneca PLC |
| 2019 | $132.8B | $95.5B | AstraZeneca PLC |
| 2018 | $97.9B | $70.6B | AstraZeneca PLC |
| 2017 | $85.9B | $106.5B | Philip Morris International Inc. |
| 2016 | $64.5B | $88.7B | Philip Morris International Inc. |
| 2015 | $76.6B | $81.7B | Philip Morris International Inc. |
| 2014 | $76.2B | $72.0B | AstraZeneca PLC |
| 2013 | $61.7B | $73.6B | Philip Morris International Inc. |
| 2012 | $46.3B | $68.5B | Philip Morris International Inc. |
| 2011 | $42.7B | $62.0B | Philip Morris International Inc. |
| 2010 | $40.3B | $44.3B | Philip Morris International Inc. |
| 2009 | $38.9B | $34.8B | AstraZeneca PLC |
| 2008 | $32.3B | $29.8B | AstraZeneca PLC |